Client News
Filter by:
- Dec 14 2022 Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
- Dec 13 2022 Investigators Present Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML at the 2022 American Society of Hematology Annual Meeting
- Dec 13 2022 Salarius Pharmaceuticals Presents SP-3164 Data Demonstrating Activity in Preclinical Lymphoma Models at the American Society of Hematology Annual Meeting
- Dec 8 2022 Ecolab Appoints Eric Green to Board of Directors
- Dec 8 2022 Ecolab Increases Cash Dividend 4%
- Dec 7 2022 Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro
- Dec 5 2022 Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing
- Dec 2 2022 Genprex to Present at Upcoming December Investor Conference
- Dec 1 2022 Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
- Nov 30 2022 Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022